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Models for all-cause mortality among 45000 men and women with cancer in 12 different sites were estimated, 
using register and census data for complete Norwegian birth cohorts.  This observed-survival method seemed to 
be an adequate approach. The results support the idea that women who were pregnant shortly before a breast 
cancer diagnosis may have a poorer prognosis than others. In principle, such an effect may also reflect that these 
women have a young child during the follow-up period, and are burdened by that. However, this social 
explanation can hardly be very important, given the absence of a corresponding significant effect in men and for 
other cancer sites in women. Breast cancer is different from other malignancies also with respect to the effect of 
parenthood  more generally, regardless of the timing of the pregnancies. On the whole, male and female cancer 
patients with children experience a lower mortality than the childless, although without a special advantage 
associated with adult children. This suggests a social effect, perhaps operating through a link between 
parenthood, life style and general health. No parity effect was seen for breast cancer, however, which may signal 
that the social effect is set off against an adverse physiological effect of motherhood for this particular cancer. 
Among men, both marriage and parenthood were associated with a good prognosis. Married male cancer patients 
with children had a mortality 1/3 lower than that among the childless and never-married. Women who had never 
married did not have the same disadvantage.     3
Some studies have addressed the importance of education, social status, or marital status for 
cancer survival. The results are quite mixed, but, on the whole, the evidence suggests that 
people who have high education or are married fare better than others when faced with a 
malignant disease. For example, these groups have been found to have a survival advantage of 
about one year (as a crude average over many sites) even in the supposedly egalitarian 
Norwegian society, with a public health care system
1,2. Because stage at the time of diagnosis 
has been controlled for in many of these studies, the socio-demographic gradients must be a 
result of differences in people's health at the time of diagnosis or health behaviour afterwards 
(so-called 'host factors'), the treatment that is offered, or the patients' ability to make the best 
out of this treatment. Documentation of such differentials in survival and identification of the 
casual pathways may, of course, serve as important underpinning for health policy 
discussions.  
There are many possible reasons why marital status may have a bearing on host factors 
that are crucial for the development of the disease, or on treatment. For example, partners may 
provide care and other kinds of assistance, add to the socio-economic resources, or exert 
social control on behaviour. There may also be a selection of healthy people into marriage. In 
addition, the presence of children is linked with marital status  (although to a lesser extent 
among young cohorts in Nordic countries than in many other populations), and may 
contribute to the relationship through similar mechanisms. For example, the poor prognosis 
among the never-married has been suggested to be partly due to a lack of support from or 
involvement with children. (The divorced and widowed have no partner to rely on either, but 
may benefit from parenthood, depending on the contact they have with their children.) 
Little is actually known, however, about the importance of children for prognosis. 
Some authors have estimated the effect of the patients’ number of children, but the results are 
mixed, and the reasons for any such effect are poorly understood. The main underlying idea is   4
that there may be hormonal or other physiological effects of a pregnancy on the malignant 
development. Hardly any attention has been paid to the possibility that children may be a 
source of support or for other reasons be linked with a healthier lifestyle or contribute to a 
more efficient treatment. In accordance with this biomedical perspective, the focus has been 
on women exclusively. However, one may learn much from taking a look at men as well. If 
effects are found, and they are similar in men and women, a social or behavioural explanation 
seems most plausible.  
  Some studies have also addressed the impact of a pregnancy shortly before diagnosis 
on cancer survival, and discussed the potential importance of various physiological processes, 
as well as a possible delay in diagnosis and treatment. However, the fact that patients who 
were pregnant at this time also have a fairly young child, who may be less of a support than 
older children and actually very demanding, has been overlooked. Estimates for men would 
give an impression of the relevance of this explanation. 
  Many of these studies of reproductive factors as determinants of cancer survival have 
been on breast cancer, some have been on colorectal cancer or malignant melanoma, and a 
smaller number on, for example, cervical or ovarian cancer. When searching for possible 
social effects of childbearing, it is, of course, particularly valuable to consider cancers in other 
sites than the reproductive organs, and which can occur also in men. In the present study, the 
survival from 12 common cancers was analysed, for men as well as women. One main 
objective was to estimate effects of number and age of children and pregnancy shortly before 
diagnosis, and to compare these effects across sexes. Another goal was to check whether a 
considerable part of the marital status effects in simpler models could be attributed to such 
reproductive factors. Some attention was also paid to conceptions after diagnosis and age at 
first birth. The data were from registers and censuses, and cover complete Norwegian birth   5
cohorts. Whereas most other studies of reproductive factors and cancer survival have included 
about 1000 patients or fewer, the Norwegian data include 45000.  
 
 




The data file includes life histories up through 1999 for all men and women with a Norwegian 
identification number (i.e., all those who have lived in Norway for some time after 1960), and 
is an updated version of the file used in previous studies.
1-3 The socio-demographic 
biographies have been extracted from the Population Censuses of 1960, 1970, 1980 and 1990 
and the Norwegian Population Register, and include information about date of death, all 
changes in residence 1964-1999, marital status as of 1960 and 1971-1999, and educational 
level as of 1960, 1970, 1980 and 1990. For those born 1936 or later, there are also complete 
maternity or paternity histories, i.e. date of birth of each child for which the person is 
registered as mother or father. These register and census data have been linked with data from 
the Norwegian Cancer Registry, which from 1960 has recorded information on all cancer 
cases in the population (site, basis for the diagnosis, histological grade and type, and stage of 
the disease at the time of diagnosis) along with the personal identification number.  
  The study was restricted to the 31998 women and 13272 men who were born after 1935 
and who were at least 20 years old when they were diagnosed with a first cancer in one of the 
fol1owing twelve sites between 1960 and 1999: stomach (518 women and 811 men), colon 
(1795, 1631), rectum (948, 1076), pancreas (354, 437), lung (1552, 2273), breast (12076), 
cervix(4294), ovary (3544), malignant melanoma (4235, 3268), brain (901, 1292), non-  6
Hodgkin's lymphoma (984, 1366) or leukaemia (797, 1118). Cancers diagnosed at autopsy 
were excluded.  
  These were the most common cancers to die from in the relevant ages and years. There 
were 8772 deaths to women with these cancers within 10 years of diagnosis, whereas the 
corresponding figure for men was 6327. Inclusion of patients diagnosed with other types of 
cancer would have expanded the material by one-third, but without giving appreciably 
different estimates, according to additional model runs.  




A discrete-time hazard regression model for all-cause mortality in the selected group of 
cancer patients was estimated. This is essentially the so-called observed-survival approach, 
whose limitations are discussed below. Each person contributed a series of one-month 
observation intervals from the time of diagnosis and up to 10 years onwards, unless death or 
emigration occurred before that, or until the end of 1999.  
  The focus was on reproductive variables and marital status. Age, period, cancer site, 
stage, duration since diagnosis, and education can be considered control variables. 
  The variables were updated every month, and referred to the situation in that month 
(parity, age of the children, post-diagnostic conception), the beginning of the calendar year 
(marital status after 1971), the time of the last previous census, which may be up to 10 years 
earlier (marital status before 1971 and educational level), or the time of the diagnosis (disease 
characteristics and the pre-diagnostic conception variable). All covariates were categorical. 
The categories were defined after extensive experimentation, to make sure that no important 
patterns were concealed.    7
  To make the comparison between the sexes more relevant, models were estimated also 
for the sub-group of women diagnosed with a cancer in other sites than the breasts and the 
reproductive organs. Besides, some models were estimated separately for each site (rather 
than including interactions with the site variable). These are not shown below, except the one 
for breast cancer, which is a particularly common malignancy.   
  Preliminary analysis showed that inclusion of histological grade (when relevant) was 
unimportant for the estimates in focus, just as in previous studies of cancer survival and social 
or marital status. Histological type and sub-site were included in some models estimated 






Effects of reproductive variables, education and marital status are shown in Table 1. Age, 
period, cancer site, stage, and duration since diagnosis were quite important as control 
variables, in the sense that that their inclusion had an appreciable influence on the estimates in 
focus, but their effects were as expected and are not shown. Conversely, educational level 
turned out to be an unimportant control variable, but the effects are nevertheless shown, 
because of the considerable research interest in social differentials. The effects of education 
were very similar to those reported in the abovementioned Norwegian study on social 
gradients in cancer survival, which was based on a larger number of somewhat older women 
followed only up to 1991.
1 
 
  (Table 1 about here)   8
Number of children 
 
Female cancer patients with children had a mortality significantly lower than the childless. 
(This can be seen from Table 1, first column, where parity effects should be interpreted as the 
difference between the childless women and those with 1-2 or 3 or more children who had not 
been pregnant after or less than 4 years before diagnosis and who had no adult child.) There 
was no difference between those who had 1 or 2 children and those who had more. Having 
only adult children was not associated with any additional advantage. 
When the cancers in the breasts and reproductive organs were excluded, parity effects 
became somewhat stronger (reaching about 25%; see column 2), and they were very similar to 
those among men (column 4). An effect of adult children was not seen in these models either.  
  Models estimated separately for each cancer site gave large standard errors, but a 
significant beneficial effect of having children nevertheless appeared for many sites for both 
sexes (not shown). Moreover, the estimates pointed in this direction for most of the other 
sites. A non-significant harmful effect of childbearing was estimated for ovarian cancer (not 
shown), and there were only weak indications that childbearing was linked with a good 
prognosis for breast cancer (column 3). These results for breast cancer and ovarian cancer are 
consistent with the stronger parity effects estimated when cancers in the breasts and 
reproductive organs were excluded.  
 
Timing of childbearing relative to diagnosis 
 
When all female cancer patients were considered, those who had conceived a child (who was 
later born live) 10-24 months before diagnosis showed a relatively high mortality, 26% above 
that of the reference group. The estimate associated with a pregnancy at the time of diagnosis   9
was of the same size, but not significant. Models estimated separately for all cancer sites 
showed a significant effect only for breast cancer (not fully shown). When cancers in the 
breasts and reproductive organs were excluded, the point estimate suggested a harmful effect 
of a recent pregnancy, but significance was not attained.  For men, there was a strong 
indication of a relatively good prognosis if they had conceived a child who was still not born 
at the time of diagnosis. However, the estimate for those who had conceived about a year 
earlier pointed in the opposite direction.  
  Women who became pregnant after diagnosis had a much lower subsequent mortality 
than those who did not. The effect was significant also when the cancers in the breasts and 
reproductive organs were excluded. A weaker, but still significant, effect was estimated for 
men.  
 
Marital status  
 
Marital status was included in these models. Otherwise, about 6% sharper effects of 
childbearing would have been seen for men, while estimates for women would have been 
largely the same  (not shown). Never-married male cancer patients had a 16% higher 
mortality than the married, and the divorced or separated a 11% higher mortality. Both these 
differences were significant. The estimates suggested a high mortality also for  the much 
smaller group of widowers, but were not significant. Smaller differences were seen among 
women. A significant 10-12% excess mortality was found for those who were divorced or 
separated, while there was no excess mortality for the never-married and widowed.   
  Effects of being never-married (but not of being formerly married) would have been 
sharper in the absence of reproductive variables in the models. These simple models revealed 
an excess mortality of 1.45 (CI 1.34-1.59) for never-married men and 1.14 (CI 1.06-1.23) for   10
never-married women (not shown). (Except for the very high mortality among never-married 
men, the effects of marital status in these models were of the same size as those found in the 
previous Norwegian study, which was based on a larger number of somewhat older women 
followed only up to 1991.
2) 
  Combined effects of marital status and parity were also estimated (not shown). Most 
interestingly, married men with children had a mortality 1/3 lower than that of the childless 
and never-married.  
 
 
Age at first birth  
 
The importance of age at first birth was checked in models restricted to parous women. No 
significant effects appeared for either sex (Table 2). Effects have been seen for breast cancer 
patients in some previous studies, but did not show up here.  
 





Number of children  
 
Models estimated for all cancer sites combined showed that, even when marital status is taken 
into account, parenthood is linked with improved prognosis. The difference was found to lie 
between the childless and those with at least one child. When cancers in the breasts and   11
reproductive organs were excluded, the effects were very similar in men and women. A 
simple and plausible interpretation would be that, for these sites, the explanation is purely 
social. However, one cannot exclude the possibility that the social effect of motherhood 
actually is sharper than that of fatherhood, because of women’s often stronger involvement 
with children, and that this is outweighed by an adverse physiological effect.   
Another interesting observation is that there was no additional beneficial effect of 
having adult children. This suggests that children are not primarily important as, for example, 
caregivers or to attract additional treatment resources. A more plausible explanation may be 
that children tend to induce a healthier life-style in their parents. Conversely, there may be a 
selection of people with good health or health behaviour into parenthood. A better health at 
the time of diagnosis, or more advantageous health behaviour afterwards, may in turn be 
important for prognosis. Another possibility is that those who have children, of any age, are 
particularly eager to put up a fight when faced with a potentially fatal disease.  
Such a beneficial effect of parenthood has not been well established in the literature. 
The association between fatherhood and men's survival prospects has hardly been addressed 
at all, whereas the studies on women have provided mixed results. For example, no parity 
effects were seen in Norwegian
4 and Australian
5 women with colorectal cancer, whereas a 
Canadian study showed a better prognosis for this kind of cancer among parous than 
nulliparous women
6. The evidence from some studies of other cancer sites has been no less 
ambiguous.
7-11 Moreover, none of those have seen significant parity effects have taken them 
as indications of largely social or behavioural mechanisms.  
The results for breast cancer were different. No clear parity effects were seen in the 
Norwegian data. At least, this lack of effect fits with the diverging estimates reported also for 
this type of cancer in the literature. In a fairly large study of about 5000 Danish women with 
breast cancer, Kroman et al. 
12 only saw very weak indications of a protective effect of   12
motherhood.  Clear parity effects were not seen by Lethaby et al.
13, Schouten et al. 
14 or 
Reeves et al. 
15 either. In contrast to this, however, a relatively poor prognosis among 
American women  with at least one child 
16 or at least three children 
17 has been reported. 
Similarly, it was found in a Canadian study that the small group of breast cancer patients with 
five or more children did not fare quite as well as others.
18 
The absence of a parity effect on breast cancer survival in the Norwegian data is likely 
to reflect a combination of a social effect, which should be just as relevant for this malignancy 
as for any other, and an opposite physiological effect.   
 
 
Pregnancy at the time of diagnosis or shortly before  
 
A review by Antonelli et al.
19 concluded that pregnancy-associated breast cancers might tend 
to be detected relatively late, but that there was little evidence of a poor survival above and 
beyond that.  However, a more recent large Danish study
20 showed that breast cancer 
diagnosis sooner than two years after birth was associated with a relatively poor prognosis, 
irrespective of stage. The risk factor was estimated to be about 1.6. A much larger effect was 
found in a smaller study from the United States.
17  
The present study lends further support to the idea that a pregnancy-associated breast 
cancer may be particularly harmful. A relatively poor survival was estimated for women with 
a breast cancer diagnosed 10-24 months after pregnancy. The effect was not very different 
from that estimated in the Danish study. No effect was seen among those with a pregnancy 2-
4 years before diagnosis.  
  In addition to the possible delay in diagnosis (less relevant explanation here, where 
stage has been taken into account), and perhaps also delay in treatment, it has been suggested   13
that effects of pregnancy may be a result of hormonal or immunological changes. Besides, 
many women who were pregnant shortly before diagnosis breastfeed at the time of diagnosis. 
Lactation was associated with a relatively poor prognosis in a Canadian study
18, while there 
were only weak indications in this direction in Norway
21.  
In principle, the estimated effect in the present study, as well as in others, may reflect 
that women who were pregnant at the time of diagnosis or some time before also had a young 
child during much of the follow-up period. This could perhaps affect prognosis because of the 
special burdens associated with young children, to be set off against any general social 
advantage of parenthood discussed above. However, an effect was not seen in men. This does 
not exclude the possibility of such a social effect in women, but one would at least expect it to 
show up generally, and not only for breast cancer. The point estimate suggested a harmful 
effect for malignant melanoma (not shown), which is one of the cancer types that have 
received most attention from this perspective in the literature, and for all cancers outside the 
‘female organs’ pooled together, but these effects were not significant. (On the whole, there 
seems to be little support for such a relationship in other studies also.
19,22) If the effect of a  
pregnancy shortly before diagnosis is really weak for these cancers, the social contribution to 
it must also be weak, and it would be reasonable to conclude that the poor prognosis of 
pregnancy-related breast cancers largely hinges on physiological factors.   
 
 
Pregnancy after diagnosis 
 
In two Nordic studies, it was shown that women who became pregnant after breast cancer 
diagnosis had a better prognosis than others
23,24, and it was concluded in a review that it was 
not harmful for breast cancer patients to get pregnant
25.  A similar conclusion was drawn with   14
respect to malignant melanoma
22.  The Norwegian data revealed a more general effect for the 
cancer sites considered, significant for women as well as men.  
A suggested also by others, an obvious explanation for such an effect is that only 
women who feel rather well and perhaps have heard that they have good survival chances 
(given recorded stage of the tumour at the time of diagnosis) may consider it wise and have 
the energy to bear a child. Sankila et al.
24 called this a ”healthy mother effect”. This study 
suggests that there may also be a “healthy father effect”, although perhaps weaker because the  
burdens placed on the fathers may be smaller. (The confidence intervals overlapped, though) 
An adverse physiological effect of pregnancy after diagnosis cannot be excluded, of course. In 
principle, the “healthy mother effect” may be even stronger than suggested by these estimates, 





In a previous study of the importance of marital status for cancer survival, it was suggested 
that childbearing was one among several possible intermediate variables (see further 
discussion elsewhere
2). The present study confirmed this, in the sense that inclusion of 
reproductive variables reduced the excess mortality among the never-married cancer patients 
to half its original size. However, a significant effect remained for men, and divorce was 
associated with poor survival for both sexes. The higher mortality among divorced female 
cancer patients than among other patients who were not married may possibly be a result of 
selection. Whereas family research has shown a number of individual and community 
characteristics to influence formation and disruption of marriage in a similar way, it is not 
impossible that there also are some characteristics that are more strongly linked with being   15
divorced than being never-married, in addition to having a harmful influence on the 
development of a malignancy. Moreover, one might speculate whether such selection 
mechanisms differ by sex, because divorced men did not display a particularly high mortality 
compared to other men without a spouse.  
  In conclusion, a man seems to benefit from having a wife, as well as from having 
children (unless these effects are entirely due to selection). This is less obvious for women, 
whose entry into marriage is not associated with any survival advantage. For them, it is only 
childbearing that ‘confers protection’, in addition to the avoidance of divorce. 
  Models estimated only for the period after 1970, for which there is annual data on 
marital status, and for ages above 40, when the never-married are a more select group and less 
likely to be cohabitants, gave very similar effects (not shown). 
 
Age at first birth 
 
Many studies have shown a sharp relationship between age at first birth and the breast cancer 
incidence, reflecting perhaps hormonal and immunological processes during pregnancy. Some 
researchers have therefore also checked its prognostic importance, although it is probably less  
reasonable to expect an effect of processes so far back in time than of the more recent 
reproductive events.  
Kroman et al.
12 reported significantly better breast cancer prognosis among women 
who had their first child in their 20s than among those who entered motherhood as teenagers. 
There were also indications of a relatively poor survival among those who started 
childbearing late. However, in a Canadian
18 and an American
16 study, age at first birth was 
not found to affect prognosis. Survival effects were not found in Norwegian
4 and Australian
5 
studies of colorectal cancer survival either.    16
  In the present study, age at first birth did not have an effect in any model, not even for 
breast cancer patients. This indicates that future research perhaps should focus less on this and 
more on other reproductive variables.  
 
 
The observed-survival approach  
 
Generally, the observed-survival approach employed in this study does not always give a 
good impression of the aggressiveness of the disease, because some of the deaths may be 
completely unrelated to the disease. Two alternative approaches have been often used in 
cancer survival studies: the relative-survival approach (which is a comparison of all-cause 
mortality in cancer patients with that in the ‘normal’ population), or the corrected-survival 
approach (in which it is censored when a death not recorded as due to cancer occurs).  
  The relative-survival approach is usually based on only age, sex and period variations in 
‘normal’ mortality. In a few extended versions, however, other socio-demographic variations 
have been taken into account. One set-up that allows for this is the following mixed additive-
multiplicative hazard model
26:  
(1)       µ = e
bx + y  e
cx  e
dz, 
where  µ is all-cause mortality,  x is a vector of socio-demographic co-variates (including 
age), b and c are effect vectors, and y is a cancer-diagnosis indicator that takes the value 1 
from the time of a cancer diagnosis (if any) and otherwise is 0. The co-variate vector z 
includes various characteristics of the cancer, with no counterparts among people without a 
cancer diagnosis, and d is the corresponding effect vector. For a cancer patient with 
characteristics x, mortality is thus e
cx  e
dz higher than for a similar individual without such a 
diagnosis. (This model requires data for a combined sample of patients and other people.)    17
  Taking a wider range of socio-demographic variation in 'normal' mortality into account 
has been shown by Kravdal
26 to be important for the less aggressive cancers that do not 
strongly dominate mortality, such as localized prostate cancer, but not when several common 
cancers are pooled together. In his estimation of such ‘overall’ marital and educational 
differentials in survival, he found that one might exclude the corresponding variables from the 
'normal' mortality without making any large mistake. In fact, one might omit the ‘normal’ 
mortality altogether, and simply estimate an all-cause mortality model for patients. The latter 
is a continuous-time version of the discrete-time model estimated in the present study.  
  One might expect the consideration of ‘normal’ mortality to be even less important in 
this study that includes younger individuals than in the study by Kravdal referred to above. 
On the other hand, a somewhat different set of cancer sites have been selected and other 
socio-demographic variables are in focus. To be on the safe side, results from the discrete-
time model for cancer patients were therefore compared with those from model (1). (Models 
for corrected survival could not be estimated, because there were no data on cause of death.) 
All the socio-demographic variables could not be included simultaneously in (1) because of 
software constraints, so a large series of comparisons were made, with different variables left 
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  WOMEN    WOMEN,  CANCER  IN  WOMEN,    MEN 
     BREASTS,  CERVIX  AND    BREAST  CANCER 
 OVARIES EXCLUDED 
          
  Estimate     N  Estimate   N    Estimate   N  Estimate   N 
 
PARITY   
0 child
b    1    1255  1      641   1      340  1    1416 
1-2 children  0.85* (0.78-0.93)  4380  0.78* (0.67-0.88)  2158  0.91   (0.76-1.08)  1319  0.76* (0.68-0.85)  2863 
3+ children  0.88* (0.79-0.97)  3137  0.76* (0.66-0.84)  1660  1.02   (0.85-1.23)    863  0.77* (0.68-0.87)  2048 
 
AT LEAST ONE  
ADULT CHILD 
No
b   1   3241  1   1611  1   1000  1   2809 
Yes    1.01   (0.94-1.09)  5531  1.02   (0.91-1.14)  2848  1.01   (0.89-1.15)  1522  1.07   (0.98-1.17)  3518 
 
A CHILD CONCEIVED 
BEFORE DIAGNOSIS  
0-9 months before  1.21   (0.89-1.66)      41  1.32   (0.89-1.97)     26  1.28   (0.70-2.34)      11  0.81   (0.65-1.01)     87 
10-24 months before  1.26* (1.10-1.43)    259  1.18   (0.97-1.43)   126  1.56* (1.23-1.97)      86  1.12   (0.96-1.32)    181 
25-48 months before  1.06   (0.95-1.18)    430  1.01   (0.85-1.19)   183  1.10   (0.93-1.32)    167  1.03   (0.90-1.16)    314 
No
b   1   8042  1   4124  1   2258  1   5745 
 
A CHILD CONCEIVED 
AFTER DIAGNOSIS 
No
b   1   8712  1   4418  1   2506  1   6211 
Yes    0.45* (0.35-0.59)     60  0.52* (0.38-0.72)     41  0.59* (0.36-0.97)      16  0.71*  (0.59-0.87)    116 
 
MARITAL STATUS 
Never-married  1.06   (0.97-1.16)  1006  0.96   (0.84-1.09)    517  1.10   (0.93-1.29)    260  1.16* (1.05-1.28)  1197     
Married
b   1   5997  1   3034  1   1806  1   4120 
Divorced/separated  1.10* (1.03-1.17)  1367  1.12* (1.03-1.22)    699  1.08   (0.96-1.21)    346  1.11* (1.03-1.20)    937 




b   1   3259  1   1743  1       757  1   2179 
10-12 years  0.91* (0.87-0.96)  4152  0.93* (0.87-0.99)  2091  0.88* (0.80-0.97)  1264  0.91* (0.86-0.97)  3027 
13-16 years  0.83* (0.78-0.89)  1233  0.86* (0.78-0.96)    569  0.78* (0.69-0.88)    448  0.84* (0.77-0.91)    815 
17- years    0.76* (0.64-0.91)    128  0.81   (0.61-1.06)      56  0.76   (0.57-1.01)      53  0.78* (0.69-0.88)    306 
 
 
a Also age, period, cancer site (except in the breast cancer model), stage, and duration since diagnosis were included in the model. These effects were as expected and can be obtained from the author.  
b Reference group 
 
 
* significant at the 0.05 level;  N = number of deaths in this group  




  WOMEN    WOMEN,  CANCER  IN  WOMEN,    MEN 
     BREASTS,  CERVIX  AND  BREAST  CANCER 
     OVARIES  EXCLUDED 
     
  Estimate     N  Estimate   N    Estimate   N  Estimate   N 
 
AGE AT FIRST  
B I R T H   ( y e a r s )         
-19    0.95  (0.88-1.02)  1182  0.93  (0.84-1.03)    628  1.07  (0.92-1.24)   261  1.13  (0.95-1.35)    156 
20-22
b   1   2408  1   1266  1       605  1       981 
23-25    0.99  (0.93-1.05)  1915  0.97  (0.88-1.06)    963  1.00  (0.88-1.12)   599  0.98  (0.90-1.06)  1424 
26-28    0.94  (0.87-1.02)  1094  0.92  (0.82-1.03)    536  0.88  (0.77-1.02)   358  1.00  (0.92-1.10)  1114 
29+    1.01  (0.92-1.11)    917  1.02  (0.90-1.16)    424  1.00  (0.85-1.17)    359  1.00  (0.90-1.11)  1229 
 
 
a Also age, period, cancer site (except in the breast cancer model), stage, duration since diagnosis and the variables shown in Table 1 were included in the models, which were restricted to parous women. 
b Reference group 
 
N=Number of deaths in this group 
 